New Medicare Regulation Aims to Cut Drug Prices for Hospitals
The new Medicare regulation aims to reduce drug costs for hospitals, predicting $1.1 billion in savings for beneficiaries. Learn more about this significant change.
The new Medicare regulation aims to reduce drug costs for hospitals, predicting $1.1 billion in savings for beneficiaries. Learn more about this significant change.
Discover proposed Medicare payment adjustments for 2027, impacting hospital funding and healthcare quality. Stakeholders urged to comment by August 31.
Discover ASCO's updated 340B Drug Pricing Program policy aimed at enhancing access to oncology care for underserved populations.
Florida hospital executives advocate for vital policy changes to improve healthcare access and affordability. Discover key insights from their D.C. meetings.
Discover how Plenful's MFP Intelligence optimizes Medicare refunds, enhances pharmacy operations, and improves compliance across health systems for financial stability.
Discover how RxParadigm's strategic alliance enhances compliance and efficiency for community health centers through innovative 340B drug management solutions.
Discover how WSHA is shaping healthcare legislation in Washington, advocating for vital bills and addressing pressing issues like drug pricing and medical oversight.
Explore the Fifth Circuit's ruling affecting hospital payments and 340B eligibility, highlighting key regulatory compliance challenges for healthcare providers.
CMS announces changes to Medicare drug price negotiations; ongoing litigation surrounds 340B rebate model and state drug pricing laws, affecting Medicare Advantage plans and Part D reimbursement.
CMS finalizes 2026 Medicare outpatient payment rule with expanded site-neutral payments, enhanced hospital price transparency, and telehealth supervision provisions affecting hospitals and ASCs nationwide.